Clinical Trials Logo

Other clinical trials

View clinical trials related to Other.

Filter by:

NCT ID: NCT03323307 Completed - Clinical trials for Optical Coherence Tomography (OCT) of the Retina

Low Cost OCT for Point of Care

Start date: March 28, 2018
Phase: N/A
Study type: Interventional

The purpose of this study is to compare the performance of a prototype optical coherence tomography (OCT) machine with currently available high resolution OCT machines.

NCT ID: NCT03323268 Completed - Clinical trials for Residual Cardiac Output During PVA-ECMO

Use of Exhaled Carbon Dioxyde for Monitoring the Native Cardiac Function During Mechanical Circulatory Support With Venoarterial By-pass in Intensive Care Unit

CAPNOECMO
Start date: January 12, 2016
Phase: N/A
Study type: Observational

Cardiogenic shock, the most severe form of acute heart failure, is a critical situation where the body cells lack of oxygen because of cardiac dysfunction. The failure of pharmacological therapy to maintain adequate perfusion has led to attempts to improve the circulation by the use of mechanical circulatory support devices. Peripheral veno-arterial support (PVA-ECMO) is the most frequently used device. It consists of extracorporeal circulatory support. Venous blood is aspirated via the right atrium and reinjected into the descending aorta via the femoral artery. As a consequence of this by-pass, pulmonary artery flow and residual left ventricle ejection can fall drastically until zero in the most severe patients. A minimal transpulmonary blood flow is crucial to avoid left heart cavities and pulmonary artery and left heart cavities thrombosis. The gold standard technique to monitor transpulmonary blood flow is right-heart cavities catheterism (Swan-Ganz catheter) but it represents major limits: invasive technique, limited duration of utilization because of septic risk, physical limit of flow measurement (under 1 liter/minute). End-tidal pressure carbon dioxide (Pet CO2) monitoring (or capnography) is a routine and non-invasive measure in ventilated patients. Previous studies have shown that changes in PetCO2 can measure changes in cardiac output in anesthetized patients and that PetCO2 is a useful index of pulmonary artery blood flow during separation from cardiopulmonary bypass. The aim of this study is to demonstrate that PetCO2 is correlated to transpulmonary blood flow in patients under PVA-ECMO and that exhaled CO2 can provide an on-line, continuous, and noninvasive monitor of residual outflow from the heart during PVA-ECMO.

NCT ID: NCT03323086 Completed - Clinical trials for Sexually Transmitted Diseases

Women SHARE Study: Reducing Sexual Risk

HIV
Start date: October 18, 2017
Phase: N/A
Study type: Interventional

This study will investigate whether BI and technology extenders are feasible and acceptable for female patients at a reproductive health center (ages 18-29).

NCT ID: NCT03322917 Completed - Clinical trials for Dry Eye After LASIK-Laser in Situ Keratomileusis

Ocular Surface Syndrome Post-lasik, Outcomes of Treatment With Platelet Rich Plasma

PRP-OSS
Start date: July 1, 2008
Phase: Phase 2
Study type: Interventional

To evaluate the efficacy of autologous platelet-rich plasma eye drops (E-PRP) for the treatment of chronic ocular surface syndrome (OSS) following laser in situ keratomileusis (LASIK).

NCT ID: NCT03322904 Completed - Clinical trials for Autonomic Nervous System Diseases

Sympathetic-parasympathetic Ratio of Our Gaze

Start date: March 10, 2016
Phase: N/A
Study type: Observational

ABSTRACT BACKGROUND The existence of the retinohypothalamic pathway suggests that light may influence autonomic outflow activity. The objective of this study was to examine the correlation between the estimated iris muscle sympathetic‒parasympathetic area (IRIS) ratio and the sympathetic-parasympathetic ratio (low frequency [LF]/high frequency [HF] ratio). METHODS The study population consisted of 200 females and 200 males (mean age, 32.4 ± 7.1 years). The IRIS ratio was determined from digital photographs of the iris in a computer setting. The LF/HF ratio was determined from records of heart rate variability obtained using a Holter implementation.

NCT ID: NCT03322124 Completed - Clinical trials for Inhibition of Plaque Formation (by Gingivitis-Index =1.5)

Study to Assess the Inhibition of Plaque Formation in Subjects With a Gingival Index ≤1.5

Start date: January 22, 2018
Phase: Phase 3
Study type: Interventional

The objective of the study is to demonstrate the superiority of 0.1% octenidine mouthwash (Octenidin Mundspüllösung, OML) to placebo (PLAC) in the inhibition of plaque formation. The study will consist of a 14-day screening period and a 5-day treatment period.

NCT ID: NCT03321825 Completed - Clinical trials for Moderate to Severe Midface Volume Deficit

Evaluation of the Merz Cheek Fullness Assessment Scale in the Treatment of Midface Volume Deficit

Start date: September 29, 2017
Phase: N/A
Study type: Interventional

Evaluation of the sensitivity of the Merz Cheeks Fullness Assessment Scale (MCFAS) and the clinical relevance of aesthetically pleasing outcomes by detecting changes in cheek appearance after Belotero® Volume Lidocaine injection. The safety objectives include the identification and description of adverse events (AEs), adverse device effects (ADEs), serious adverse events (SAEs), serious adverse device effects (SADEs), anticipated serious adverse device effects (ASADEs) and unanticipated adverse device effects (UADEs) during the course of the study. Additionally, common treatment site responses (CTRs) will be assessed.

NCT ID: NCT03321396 Completed - Clinical trials for Submucosal Tumor of Gastrointestinal Tract

Hydrogel Injection to Assist Endoscopic Submucosal Dissection

Start date: September 1, 2017
Phase: N/A
Study type: Interventional

The aim of the investigators' study is to evaluate the mucosa-elevating capacity and clinical safety of Sodium Alginate (SA) mixed with Calcium Lactate in assisting Endoscopic Submucosal Dissection/Endoscopic Mucosal Resection.

NCT ID: NCT03321253 Completed - Retinal Detachment Clinical Trials

Changes of Macular Pigment and Parameters of Eyes After YAG Laser Treatment in Cases With Capsule Opacification

Start date: October 23, 2015
Phase: N/A
Study type: Interventional

It has been hypothesized that potential effects of laser Nd: YAG laser posterior capsulotomy may affect macular pigment as well as choroidal thickness, macular thickness and anterior chamber parameters, so it was aimed to investigate possible effects of Nd: YAG laser posterior capsulotomy on macular pigment optical density, choroidal thickness, macular thickness and anterior chamber parameters in cases with posterior capsule opacification in this study.

NCT ID: NCT03320967 Completed - Clinical trials for Arterial Hypotension in Critically Ill Neonatal and Pediatric Patients

Copeptin and Arterial Hypotension in Critically Ill Paediatric and Neonatal Intensive Care Patients

COPNIC
Start date: December 4, 2017
Phase:
Study type: Observational

Blood copeptin will be measured during the routine treatment of neonates, children and adolescents on the Intensive Care Unit of the University Children`s Hospital Zurich at different time points (admission, 12, 24, 48, 96, 168 hours after admission). These values will be primarily analysed for their variability and their association with arterial hypotension. Blood samples will be drawn together with otherwise medically indicated blood withdrawals to avoid extra harm. Further, copeptin values will be compared to clinical and vital parameters, all of them open-label available during clinical routine. Copeptin`s predictive value for patients` outcome will be analysed as secondary outcome.